Barayan, Maria Angelie M.

HRN: 06-18-65  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2026
CO-AMOXICLAV 625MG (TAB)
07/21/2026
07/28/2026
PO
625mg
BID X 7 Days
S/P NSVD With Perineal Laceration; Thinly MSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: